Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudomonas aeruginosa

ABSTRACT: VIM-60 producing multidrug-resistant P. aeruginosa in Japan

PROVIDER: PRJDB8046 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR171119_1.fastq.gz	Fastqsanger.gz
	DRR171119_2.fastq.gz	Fastqsanger.gz
	DRR171120_1.fastq.gz	Fastqsanger.gz
	DRR171120_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Pseudomonas aeruginosa

Project description:Detection of VIM type-producing multidrug-resistant Pseudomonas aeruginosa in Japan

| PRJDB8977 | ENA

Pseudomonas aeruginosa

Project description:Detection of GES-5-producing multidrug-resistant Pseudomonas aeruginosa in Japan

| PRJDB4746 | ENA

Pseudomonas aeruginosa

Project description:Detection of GES-5-producing multidrug-resistant Pseudomonas aeruginosa in Japan

| PRJDB6635 | ENA

Pseudomonas aeruginosa

Project description:VIM-2 and OXA-4 co-producing Pseudomonas aeruginosa

| PRJNA634848 | ENA

Pseudomonas aeruginosa

Project description:Prolonged VIM-2 producing P. aeruginosa outbreak in the intensive care units

| PRJNA1102685 | ENA

Pseudomonas aeruginosa

Project description:Genome sequencing of multidrug-resistant Pseudomonas aeruginosa 0108

| PRJNA1033452 | ENA

Pseudomonas aeruginosa

Project description:Multidrug-resistant Pseudomonas aeruginosa clinical isolates in Myanmar

| PRJDB6612 | ENA

Pseudomonas aeruginosa

Project description:Nationwide surveillance of carbapenem-resistant Pseudomonas aeruginosa in Japan

| PRJDB16993 | ENA

Antibacterial activities of the algal bromophenol methylrhodomelol against Pseudomonas aeruginosa

Project description:Methylrhodomelol (1) is a bromophenol from the red alga Vertebrata lanosa (L.) T.A.Christensen that has been associated with antimicrobial properties. Aim of the current study was therefore, to assess the antimicrobial potential of this compound in more detail against the gram-negative pathogen Pseudomonas aeruginosa. 1 exerted weak bacteriostatic activity against different strains when grown in minimal medium, whereas other phenolics were inactive. In addition, 1 (35 and 10 µg/mL) markedly enhanced the susceptibility of multidrug resistant P. aeruginosa towards the aminoglycoside gentamicin, while it did not affect the viability of Vero kidney cells up to 100 µM. Finally, pyoverdine release was reduced in bacteria treated at sub-inhibitory concentration, but no effect on other virulence factors was observed. Transcriptome analysis of treated versus untreated P. aeruginosa indicated an interference of 1 with bacterial carbon and energy metabolism, which was corroborated by RT-qPCR and decreased ATP-levels in treated bacteria.

2024-04-07 | GSE249483 | GEO

Pseudomonas aeruginosa DHS01

Project description:Multidrug-resistant epidemic Pseudomonas aeruginosa genome sequencing (early isolate)

| PRJNA224149 | ENA